Biopeutics Co., Ltd.

Innovate to Improve Quality of Life

Home

About Us

Products

EUBEATLIN

Contact Us

Products and EUBEATLINTM

Biopeutics has a product portfolio of drugs of known clinical characteristics. These products have been on the market for years and their safety is well established and documented. Based on the vast experience and knowledge of using these products, Biopeutics is developing new clinical indications for cardiovascular dysfunctions. This model allows us to save time, reduce cost and lower risk for new product development.

Biopetuics is developing various ranges of products to treat cardiovascular problems and peripheral arterial occlusive disease. Biopeutics is currently focusing on developing treatments for chronic heart failure, since this is one of the most challenging diseases, with poor prognosis in its advanced stage.

Our goal is to become a leading R&D company in the cardiovascular field.

Copyright © 2023 Biopeutics Co. Ltd. All rights reserved.